Skip to Main Content

Advertisement

Skip Nav Destination

Abstract 1791: Epigenetically upregulating TROP2 enhances therapeutic efficacy of TROP2 ADC sacitizumab govitecan

Cancer Res (2022) 82 (12_Supplement): 1791.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal